SCHEMBL18323129

SCHEMBL18323129

NC(=O)c1ccc(C(=O)Nc2cc(Br)c(S(N)(=O)=O)cn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 8/20 0.45
▸ KLK1 P06870 1/20 0.45
▸ MAP3K5 Q99683 5/20 0.43
▸ MTOR P42345 1/20 0.43
▸ CCNA2 P20248 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15907221 0.81 MTOR (0.56) MAP3K5MTORCCNA2CDK2CCNA1
SCHEMBL18323128 0.80 NPC1 (0.52) F10KLK1MTORMEN1NPC1
SCHEMBL18323294 0.80 NPC1 (0.49) MEN1NPC1KMT2ARAB9ARXFP1
SCHEMBL18323130 0.75 NPC1 (0.36) F10KLK1MAP3K5MTORMEN1
SCHEMBL18323127 0.70 MAP3K5 (0.39) F10KLK1MAP3K5MEN1NPC1
SCHEMBL11308749 0.67 HCAR3 (0.77) MEN1NPC1KMT2ARAB9ASMN1; SMN2
SCHEMBL4915077 0.65 NPC1 (0.60) NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL28994215 0.65 BTK (0.53) —
SCHEMBL25223941 0.63 NPC1 (0.56) F10MEN1NPC1KMT2ARAB9A
SCHEMBL13210699 0.62 KMT2A (0.73) MEN1NPC1KMT2ARAB9ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 — — US disclosed
Send feedback